ANTHERA PHARMACEUT (ANTH)

0.08
OTC Markets
Prev Close 0.08
Day Low/High 0.07 / 0.08
52 Wk Low/High 0.07 / 2.97
Exchange OTC Markets
Market Cap 1.99M
Div & Yield N.A. (N.A)
Jim Cramer: Valuations Now Have No Relation to Common Sense

Jim Cramer: Valuations Now Have No Relation to Common Sense

Analyst downgrades and mind-boggling P/E ratios do not matter in this current market.

Anthera Pharmaceuticals Announces Presentation Of Blisibimod Data At The American College Of Rheumatology Annual Meeting

Anthera Pharmaceuticals Announces Presentation Of Blisibimod Data At The American College Of Rheumatology Annual Meeting

Presentation will highlight additional analyses of the CHABLIS-SC1, Phase 3 clinical study of blisibimod

Anthera Pharmaceuticals Announces Presentation Of Blisibimod Lupus Research At The American Society Of Nephrology Annual Meeting

Anthera Pharmaceuticals Announces Presentation Of Blisibimod Lupus Research At The American Society Of Nephrology Annual Meeting

Presentation to highlight data from the CHABLIS-SC1, Phase 3 clinical study of blisibimod

Russell 2000 Skips the Party

Number of stocks making new highs keeps climbing.